Clontech Gains Access to Smart-seq2 Single-Cell RNA-Seq Technology

March 24, 2015 Leave a comment 6,775 Views

MOUNTAIN VIEW, Calif., March 23, 2015 /PRNewswire/ — Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced that it has entered into an exclusive agreement with Ludwig Cancer Research for rights to the Smart-seq2 method for single-cell RNA-seq, ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Ludwig Cancer Research

Clontech Gains Access to Smart-seq2 Single-Cell RNA-Seq Technology

RNA-Seq links with severe COVID-19 with molecular signatures of brain aging

Call for Papers – Applications of RNA-Seq in Cancer and Tumor Research

Exai Bio’s RNA sequencing-based liquid biopsy platform delivers promising data on detecting breast cancer at its earliest stages

Transcriptomic technique may help identify infections after knee and hip replacement

AS-CMC – a pan-cancer database of alternative splicing for molecular classification of cancer

Data analysis guidelines for single-cell RNA-seq in biomedical studies and clinical applications

Featured RNA-Seq Job – CCG Single-Cell/-Nucleus Sequencing Group Leader, Scientist II